熱門資訊> 正文
Autonomix Medical宣布定价500万美元私募
2025-11-18 21:59
- Autonomix Medical (NASDAQ:AMIX) stated on Tuesday that it has entered into an agreement with a single institutional investor to purchase 4.5M shares of common stock and, together with unregistered Series C warrants, to purchase up to an aggregate 9M shares of common stock, in a private placement priced at the market under Nasdaq rules.
- The combined offering price for each share of common stock and Series C warrant is $1.1107.
- The Series C warrants will have an exercise price of $0.8607 per share, will be exercisable immediately, and will expire on the five-and-one-half-year from the date of issuance.
- The gross proceeds from the offering are estimated to be approximately $5M.
- The offering is expected to close on or about November 19, 2025.
- Maxim Group LLC is acting as the sole placement agent in connection with the offering.
- Shares +58.18%.
More on Autonomix Medical, Inc.
- Autonomix Medical registers 2.5M shares for resale under $15M equity deal with Lincoln Park
- Seeking Alpha’s Quant Rating on Autonomix Medical, Inc.
- Historical earnings data for Autonomix Medical, Inc.
- Financial information for Autonomix Medical, Inc.
推薦文章
美股機會日報 | 凌晨3點！美聯儲將公佈1月貨幣政策會議紀要，納指期貨漲近0.5%；13F大曝光！巴菲特連續三季減持蘋果
美股機會日報 | 阿里發佈千問3.5！性能媲美Gemini 3；馬斯克稱Cybercab將於4月開始生產
港股周報 | 中國大模型「春節檔」打響！智譜周漲超138%；鉅虧超230億！美團周內重挫超10%
一周財經日曆 | 港美股迎「春節+總統日」雙假期！萬億零售巨頭沃爾瑪將發財報
從軟件到房地產，美國多板塊陷入AI恐慌拋售潮
Meta計劃為智能眼鏡添加人臉識別技術
危機四伏，市場卻似乎毫不在意
財報前瞻 | 英偉達Q4財報放榜在即！高盛、瑞銀預計將大超預期，兩大關鍵催化將帶來意外驚喜？
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
